CA2464306A1 - Dihydrate-ii d'olanzapine: son procede de preparation et son utilisation - Google Patents
Dihydrate-ii d'olanzapine: son procede de preparation et son utilisation Download PDFInfo
- Publication number
- CA2464306A1 CA2464306A1 CA002464306A CA2464306A CA2464306A1 CA 2464306 A1 CA2464306 A1 CA 2464306A1 CA 002464306 A CA002464306 A CA 002464306A CA 2464306 A CA2464306 A CA 2464306A CA 2464306 A1 CA2464306 A1 CA 2464306A1
- Authority
- CA
- Canada
- Prior art keywords
- olanzapine
- dehydrate
- product
- methyl
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne une nouvelle forme de dihydrate 2-methyl-4-(4-methyl-1-piperazinyl)-10<I>H</I>-thieno[2,3-b][1,5 benzodiazepine (appelé dihydrate-II d'olanzapine), son procédé de préparation et sa conversion en olanzapine de forme II. L'invention concerne également des compositions contenant le dihydrate-II d'olanzapine, l'utilisation dudit dihydrate-II d'olanzapine et des compositions contenant le dihydrate-II d'olanzapine permettant de traiter des troubles du système nerveux central.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN877/MAS/2001 | 2001-10-29 | ||
IN877CH2001 | 2001-10-29 | ||
PCT/US2002/034701 WO2003037903A1 (fr) | 2001-10-29 | 2002-10-29 | Dihydrate-ii d'olanzapine: son procede de preparation et son utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2464306A1 true CA2464306A1 (fr) | 2003-05-08 |
Family
ID=11097012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002464306A Abandoned CA2464306A1 (fr) | 2001-10-29 | 2002-10-29 | Dihydrate-ii d'olanzapine: son procede de preparation et son utilisation |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1440074A1 (fr) |
AU (1) | AU2002340328A1 (fr) |
CA (1) | CA2464306A1 (fr) |
WO (1) | WO2003037903A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7297789B2 (en) | 2002-05-31 | 2007-11-20 | Sandoz, Inc. | Process of preparation of olanzapine form I |
US7323459B2 (en) | 2002-12-24 | 2008-01-29 | Teva Pharmaceutical Industries Ltd. | Crystal forms, methods for their preparation and method for preparation of olanzapine |
DE05783995T1 (de) * | 2004-07-14 | 2007-10-11 | Shasun Chemicals and Drugs Ltd., Chennai | Verbessertes verfahren zur herstellung von form i aus olanzapin |
JP4940152B2 (ja) * | 2005-01-05 | 2012-05-30 | イーライ リリー アンド カンパニー | パモ酸オランザピン二水和物 |
CN103185759A (zh) * | 2011-12-27 | 2013-07-03 | 天津药物研究院 | 奥氮平中溶剂残留的检测方法及其应用 |
CN103848847B (zh) * | 2012-12-04 | 2018-02-06 | 广东东阳光药业有限公司 | 一种改进制备奥氮平及其晶型ii的方法 |
JP6008734B2 (ja) * | 2012-12-20 | 2016-10-19 | 株式会社トクヤマ | オランザピンii型結晶の製造方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5229382A (en) * | 1990-04-25 | 1993-07-20 | Lilly Industries Limited | 2-methyl-thieno-benzodiazepine |
EG23659A (en) * | 1995-03-24 | 2007-03-26 | Lilly Co Eli | Process and crystal forms of methyl-thieno-benzodiazepine |
ZA978515B (en) * | 1996-09-23 | 1999-03-23 | Lilly Co Eli | Intermediates and process for preparing olanzapine |
UA56184C2 (uk) * | 1996-09-23 | 2003-05-15 | Елі Ліллі Енд Компані | Поліморфна модифікація оланзапіну дигідрату d, фармацевтична композиція та спосіб лікування психотичного стану |
SK2502003A3 (en) * | 2000-08-31 | 2004-03-02 | Reddys Lab Ltd Dr | Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine |
-
2002
- 2002-10-29 EP EP02778677A patent/EP1440074A1/fr not_active Withdrawn
- 2002-10-29 CA CA002464306A patent/CA2464306A1/fr not_active Abandoned
- 2002-10-29 WO PCT/US2002/034701 patent/WO2003037903A1/fr not_active Application Discontinuation
- 2002-10-29 AU AU2002340328A patent/AU2002340328A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2002340328A1 (en) | 2003-05-12 |
WO2003037903A8 (fr) | 2004-02-12 |
WO2003037903A1 (fr) | 2003-05-08 |
EP1440074A1 (fr) | 2004-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2683040C (fr) | Formes polymorphes de chlorhydrate de 1-[4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine | |
JP4145492B2 (ja) | テトラヒドロピリドエーテル | |
SI9520091B (sl) | Soli anti-migrenskega derivata indola | |
EP1296951B1 (fr) | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3'] bipyridinyl sous forme cristalline pure et procede de synthese | |
WO2001014379A2 (fr) | Nouvelle forme cristalline de disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l- sel d'acide glutamique et procedes de preparation | |
EP3428159B1 (fr) | Formes cristallines de sel de mésylate de dérivé de pyridinyl-aminopyrimidine, procédés de préparation et applications associés | |
KR20140098074A (ko) | 7-((3s,4s)-3-[(사이클로프로필아미노)메틸]-4-플루오로피롤리딘-1-일)-6-플루오로-1-(2-플루오로에틸)-8-메톡시-4-옥소-1,4-다이하이드로퀴놀린-3-카복실산 결정 | |
NO323980B1 (no) | Krystallinsk dihydrat B eller E olanzapin, fremgangsmate for fremstilling av Form II olanzapin samt preparat | |
CA2464306A1 (fr) | Dihydrate-ii d'olanzapine: son procede de preparation et son utilisation | |
KR20090082399A (ko) | 벤조티오펜 화합물의 결정형 및 그의 제조방법 | |
WO2000078729A1 (fr) | Formes cristallines du lansoprazole | |
EP1551414B1 (fr) | Procede de preparation de forme i de l'olanzapine | |
PT752857E (pt) | Processo aperfeicoado de sintese para 6,9-bis¬(2-aminoetil)-amino|-benzo¬g|isoquinolina-5,10-diona e o seu sal dimaleato | |
EP0406719A1 (fr) | 4H-Indolo(1,2-d)(1,2,4)triazolo(4,3-a)(1,4)benzodiazépines, un procédé pour leur préparation et leur utilisation comme médicaments | |
US20040067936A1 (en) | Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine | |
KR102496869B1 (ko) | 이미다조[1,2-a]피리딘 화합물의 신규 염, 이의 결정형 및 제조방법 | |
CZ286654B6 (cs) | 2-/2-/(2-hydroxyethyl) amino/ethyl/-5-//(2-methylamino)ethyl/amino/indazol/4,3-gh/isochinolin-6(2H) on, způsob jeho výroby a farmaceutický prostředek s jeho obsahem | |
KR100825530B1 (ko) | (-)-시스-2-(2-클로로페닐)-5,7-디하이드록시-8-[4r-(3s-하이드록시-1-메틸)피페리디닐]-4h-1-벤조피란-4-온의 에탄올 용매화물 | |
EP0024582A1 (fr) | Benzodiazépinones, procédé pour leur préparation et médicaments les contenant | |
CN117321054A (zh) | 三环衍生物化合物的结晶形式、制备其的方法和包含其的药物组合物 | |
CA2007513A1 (fr) | 7-aryl- et heteroaryl ethers de la desacetyl forskoline, procede de preparation et utilisation comme medicaments | |
AU613259B2 (en) | 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridines | |
WO2003091260A9 (fr) | Nouvelle forme vi polymorphe cristalline d'olanzapine et procede de preparation | |
EP0864572A1 (fr) | Cristal d'hydrate et son procede de preparation | |
WO2008068767A2 (fr) | Nouvelle forme cristalline du lansoprazole |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |